British Journal of Dermatology · 1991 · 110 citations · 11 references
MedicineDermatologyOncologyCancer EpidemiologyCutaneous OncologyNeoplasiaMalignant NeoplasmsNeoplastic Skin LesionsNonmelanoma Skin CancerSkin Cancer EpidemiologySkin TumorsSquamous Cell CarcinomaCancer Registry MethodologyMelanoma IncidenceNon-melanoma Skin Cancer SurveillanceNonmelanoma Skin Cancer EpidemiologyNonmelanoma Skin Cancer IncidenceTumor Incidence Analysis
The trends in the incidence and the sites of primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) of the skin were examined in a defined population of 650,000 persons in the SE Netherlands during the period 1975-88. The data was obtained from the Cancer Registry in Eindhoven and was from the dermatological and surgical clinics of 12 community hospitals. The incidence rates for BCC during this period rose from 42 to 53/100,000 person years for males and 24 to 38/100,000 person years for females. The rate of incidence for SCC varied with an increase mainly among males. In about 80% of the cases BCC and SCC occurred on the head and neck. Allowing for some detection bias a rise in the true incidence of BCC and SCC was observed, with an increase in SCC only since 1982. There was a marked decline in the incidence of SCC on the lips of males. These rates and trends fit into a pattern observed in other parts of Europe.
11
The Emerging Epidemic of Melanoma and Squamous Cell Skin Cancer
Andrew G. Glass · JAMA · 1989 · 464 citations
Medicine, Dermatology, Oncology +12
Incidence of non-melanocytic skin cancer treated in Australia
Graham G. Giles, Robin Marks, Peter Foley · BMJ · 1988 · 360 citations · Full text
Medicine, Dermatology, Oncology +15
Risk of developing another basal cell carcinoma. A 5-year prospective study
June K. Robinson · Cancer · 1987 · 160 citations · Full text
Medicine, Dermatology, Oncology +11
The Anatomical Distribution of Skin Cancers
Dennis K. Pearl, Elizabeth L. Scott · International Journal of Epidemiology · 1986 · 136 citations
Medicine, Dermatology, Oncology +15